INBX

Inhibrx Biosciences, Inc. NASDAQ Listed Jun 4, 2024

Healthcare ·Biotechnology ·US · inhibrx.com

$124.44

Mkt Cap $1.8B

52w Low $10.84 78.6% of range 52w High $155.29

50d MA $83.91 200d MA $63.18

P/E (TTM) -14.2x

EV/EBITDA -9.1x

P/B 249.5x

Debt/Equity 13.4x

ROE -1752.2%

P/FCF -9.4x

RSI (14) —

ATR (14) —

Beta 1.83

50d MA $83.91

200d MA $63.18

Avg Volume 284.0K

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma. The company was incorporated in 2024 and is based in La Jolla, California.

SIC Code

2836

CIK (SEC)

2007919

Phone

858-795-4220

11025 North Torrey Pines Road · La Jolla, CA 92037 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 19, 2026	AMC	-2.08	-2.11	-1.4%	64.87	-1.5%	-6.1%	-0.4%	-2.7%	+2.5%	+1.4%	—
Nov 14, 2025	AMC	-2.08	-2.28	-9.6%	79.13	+0.0%	-2.2%	-1.9%	+3.8%	+0.9%	+6.1%	—
Aug 13, 2025	AMC	-2.92	-1.85	+36.6%	23.57	+2.0%	+1.6%	-1.0%	+1.3%	-2.4%	+3.6%	—
May 14, 2025	AMC	-2.55	-2.80	-9.8%	10.84	+1.2%	+10.9%	+13.7%	+15.0%	+20.6%	+21.4%	—
Mar 17, 2025	AMC	-2.88	-3.09	-7.3%	13.94	-2.9%	+0.4%	+0.4%	+1.1%	+2.9%	+5.6%	—
Nov 14, 2024	AMC	-3.06	-2.84	+7.2%	14.33	+0.0%	-3.5%	-5.0%	-0.3%	-2.0%	-2.4%	—
Aug 13, 2024	AMC	-3.60	125.48	+3585.6%	11.30	-0.3%	-0.1%	+9.7%	+10.3%	+14.6%	+14.2%	—
Jun 3, 2024	AMC	-1.04	-1.44	-38.5%	18.02	+2.4%	-4.5%	-6.3%	-9.9%	-7.6%	-7.9%	—
Feb 28, 2024	AMC	-1.07	-1.73	-61.7%	37.00	-0.1%	-1.0%	-1.5%	-3.7%	-3.8%	-3.5%	—
Nov 9, 2023	AMC	-1.01	-1.10	-8.9%	18.30	+1.0%	+4.4%	+7.6%	+10.5%	+10.8%	+14.8%	—
Aug 7, 2023	AMC	-1.02	-1.08	-5.9%	19.32	-0.1%	-12.0%	-18.5%	-17.7%	-17.4%	-16.8%	—
May 8, 2023	AMC	-0.84	-1.12	-33.3%	26.45	-2.8%	-0.5%	-2.2%	-5.2%	-6.5%	-4.9%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Aug 22	JMP Securities	Maintains	Market Perform → Market Perform	—	$24.16	$24.45	+1.2%	+3.5%	+3.6%	+7.3%	+13.4%	+15.4%
May 15	JMP Securities	Maintains	Market Perform → Market Perform	—	$10.84	$10.97	+1.2%	+10.9%	+13.7%	+15.0%	+20.6%	+21.4%
Mar 18	Citizens Capital Markets	Maintains	Market Perform → Market Perform	—	$13.94	$13.53	-2.9%	+0.4%	+0.4%	+1.1%	+2.9%	+5.6%
Jan 22	JMP Securities	Maintains	Market Perform → Market Perform	—	$14.19	$14.01	-1.3%	-4.2%	-7.8%	-7.3%	-12.5%	-13.7%
Jan 23	JMP Securities	Downgrade	Market Outperform → Market Perform	—	$33.33	$35.50	+6.5%	+8.9%	+8.8%	+12.5%	+12.8%	+14.0%
Nov 20	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$22.29	$22.44	+0.7%	-0.1%	-11.4%	-7.9%	-7.9%	-8.8%
Aug 23	JMP Securities	Maintains	Outperform → Outperform	—	$19.06	$19.09	+0.2%	+2.0%	-1.6%	-5.0%	+1.5%	+15.1%
May 10	JMP Securities	Maintains	Market Outperform → Outperform	—	$26.31	$26.29	-0.1%	-1.7%	-4.7%	-6.0%	-4.4%	-5.9%
Mar 8	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$23.97	$23.88	-0.4%	-2.6%	-5.1%	-10.5%	-4.8%	-1.6%
Mar 7	Credit Suisse	Maintains	Outperform → Outperform	—	$23.69	$22.76	-3.9%	+1.2%	-1.5%	-4.0%	-9.5%	-3.7%
Nov 8	Credit Suisse	Maintains	Outperform → Outperform	—	$29.08	$29.51	+1.5%	+2.0%	-0.3%	+10.7%	+12.4%	+12.8%
Oct 5	Evercore ISI	Maintains	Outperform → Outperform	—	$29.76	$28.98	-2.6%	+7.6%	+1.7%	+2.5%	+0.5%	+3.9%
Aug 25	SMBC Nikko	Maintains	Outperform → Outperform	—	$21.00	$21.41	+2.0%	+3.6%	-6.4%	-8.7%	-15.0%	-15.5%
Aug 9	Credit Suisse	Maintains	Outperform → Outperform	—	$24.73	$23.92	-3.3%	-0.8%	-4.6%	-4.9%	-1.1%	-0.2%
Mar 16	SMBC Nikko	Maintains	Outperform → Outperform	—	$20.18	$21.41	+6.1%	+12.8%	+21.0%	+25.2%	+13.2%	+17.5%
Mar 2	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$21.79	$21.79	+0.0%	-0.9%	-3.7%	-6.8%	-8.7%	-8.2%
Nov 10	Credit Suisse	Maintains	Outperform → Outperform	—	$43.88	$44.99	+2.5%	-2.1%	-0.8%	-1.5%	+1.4%	+0.1%
Nov 2	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$46.02	$45.30	-1.6%	-1.3%	-2.2%	-3.4%	-2.8%	-3.3%
Sep 21	JMP Securities	Maintains	Market Outperform → Outperform	—	$35.62	$36.80	+3.3%	+4.7%	+2.6%	+6.1%	+3.2%	+1.8%

Data updated apr 25, 2026 3:29pm · Source: massive.com